慢性疼痛治療市場- 世界の産業規模、シェア、動向、機会、予測、適応症別、製品タイプ別、流通チャネル別、地域別、競争別、2020-2030F

慢性疼痛治療の世界市場規模は、2024年に842億3,000万米ドルとなり、予測期間には1,320億8,000万米ドルに達すると予測され、2030年までのCAGRは7.76%です。

世界の慢性疼痛治療市場は、関節炎、神経障害、線維筋痛症、腰痛などの長期的な疼痛状態に苦しむ個人の増加により、大幅な拡大を経験しています。高齢者は退行性疾患や筋骨格系障害のために慢性疼痛に陥りやすいため、高齢化人口の増加が市場成長に大きく寄与しています。医学研究の開発により、非オピオイド鎮痛薬や生物学的製剤のような医薬品による介入から、神経刺激や再生医療のような非薬物療法まで、より効果的な疼痛管理ソリューションが開発されています。利用可能な治療選択肢に関する患者の意識の高まりと、疼痛管理における個別化医療の統合が、革新的な治療法の採用を促進しています。各国のヘルスケア支出の増加や償還政策の改善も市場の拡大を後押しし、患者は先進的な慢性疼痛治療によりアクセスしやすくなっています。

より安全で効果的な疼痛管理戦略への需要が主要な市場動向を形成しており、オピオイド中毒や依存性への懸念から非オピオイド療法へのシフトが顕著です。脊髄刺激や経皮的電気神経刺激（TENS）などの神経調節技術の出現は、標的を絞った低侵襲のソリューションを提供することで慢性疼痛治療に革命をもたらしています。幹細胞治療や多血小板血漿（PRP）注射を含む再生医療は、長期的な疼痛緩和と組織修復のための有望な選択肢として支持を集めています。モバイルアプリケーションやウェアラブルデバイスなどのデジタルヘルスソリューションは、遠隔モニタリング、患者参加、データ主導の治療計画を可能にすることで、疼痛管理を改善しています。薬物療法、介入療法、心理療法を組み合わせた集学的疼痛管理アプローチへの注目の高まりが、患者の転帰改善に寄与し、市場成長を促進しています。

主な市場促進要因

高齢化人口の増加

主な市場課題

オピオイド危機と規制強化

主要市場動向

非オピオイド疼痛管理の増加

オピオイドに関連する副作用や中毒の恐れから、非オピオイドの選択肢を求める患者が増加しており、代替疼痛管理ソリューションへの需要が生じています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の慢性疼痛治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 適応症別（神経障害性疼痛、鎮痛剤注入、アブレーション）
  • 製品タイプ別（医薬品、医療機器）
  • 流通チャネル別（病院・診療所、外来センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の慢性疼痛治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の慢性疼痛治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の慢性疼痛治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の慢性疼痛治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの慢性疼痛治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因と課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の慢性疼痛治療市場：SWOT分析

第14章 競合情勢

• Pfizer Inc
• Abbott Laboratories
• Eli Lilly and Company
• Novartis AG
• Johnson & Johnson
• Sanofi SA
• Teva Pharmaceutical Industries Ltd
• Baxter International
• Merck & Co. Inc
• Boston Scientific Corporation

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Chronic Pain Treatment Market was valued at USD 84.23 Billion in 2024 and is expected to reach USD 132.08 Billion in the forecast period with a CAGR of 7.76% through 2030. The global chronic pain treatment market is experiencing substantial expansion, driven by an increasing number of individuals suffering from long-term pain conditions such as arthritis, neuropathy, fibromyalgia, and lower back pain. The rising aging population contributes significantly to market growth, as elderly individuals are more prone to chronic pain due to degenerative diseases and musculoskeletal disorders. Advances in medical research have led to the development of more effective pain management solutions, ranging from pharmaceutical interventions like non-opioid analgesics and biologics to non-pharmacological treatments such as neurostimulation and regenerative medicine. Increasing patient awareness regarding available treatment options and the integration of personalized medicine in pain management are enhancing the adoption of innovative therapies. Growing healthcare expenditure and improved reimbursement policies in various countries further support market expansion, allowing patients greater access to advanced chronic pain treatments.

The demand for safer and more effective pain management strategies is shaping key market trends, with a notable shift toward non-opioid therapies due to concerns over opioid addiction and dependency. The emergence of neuromodulation technologies, including spinal cord stimulation and transcutaneous electrical nerve stimulation (TENS), is revolutionizing chronic pain treatment by offering targeted and minimally invasive solutions. Regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP) injections, is gaining traction as a promising alternative for long-term pain relief and tissue repair. Digital health solutions, such as mobile applications and wearable devices, are improving pain management by enabling remote monitoring, patient engagement, and data-driven treatment plans. The increasing focus on multidisciplinary pain management approaches, which combine pharmacological, interventional, and psychological therapies, is contributing to better patient outcomes and driving market growth.

Key Market Drivers

Increasing Aging Population

The increasing aging population is a pivotal driver for the Global Chronic Pain Treatment Market, impacting the healthcare industry in several profound ways. With age comes an increased susceptibility to chronic pain conditions such as osteoarthritis, rheumatoid arthritis, neuropathy, and musculoskeletal disorders. In 2022, the age-adjusted prevalence of diagnosed arthritis in U.S. adults was 18.9%, with the percentage rising significantly with age from 3.6% in adults aged 18-34 to 53.9% in those aged 75 and older. This heightened prevalence among the elderly directly fuels the demand for effective pain management solutions.

Advances in healthcare have resulted in extended life expectancy worldwide. For instance, in 2023, life expectancy at birth for the U.S. population increased to 78.4 years, up from 77.5 years in 2022. While this is a remarkable achievement, it also means that a significant portion of the population is living longer, thereby increasing the likelihood of experiencing chronic pain as they age. Elderly individuals commonly suffer from multiple chronic health conditions simultaneously, which can exacerbate pain symptoms and necessitate more complex and comprehensive pain management strategies.

Key Market Challenges

Opioid Crisis and Regulatory Scrutiny

The opioid crisis, characterized by the misuse and addiction to prescription opioid pain relievers, has led to heightened regulatory scrutiny on the use of opioids in chronic pain management. In response to the crisis, regulators have imposed stricter guidelines on opioid prescribing, distribution, and monitoring.

Stricter regulations have made it more challenging for patients to access opioid-based pain medications, even when medically necessary, leading to concerns about undertreated pain. Healthcare providers and pharmaceutical companies face increased legal liability related to opioid prescriptions, which can result in cautious prescribing practices and a reluctance to develop new opioid-based pain medications.

Key Market Trends

Rise in Non-Opioid Pain Management

Trend: There is a growing shift away from opioid-based pain management towards non-opioid alternatives. This trend is driven by concerns over the opioid crisis, regulatory restrictions on opioid prescriptions, and the desire to reduce the risk of addiction and overdose.

Opioid medications carry a risk of addiction and overdose, making non-opioid alternatives more attractive for patients and healthcare providers concerned about patient safety. Stricter regulations on opioid prescribing and dispensing have pushed healthcare providers to explore non-opioid treatments to comply with these guidelines.

Patients are increasingly seeking non-opioid options due to the fear of opioid-related side effects and addiction, creating a demand for alternative pain management solutions.

Key Market Players

Pfizer Inc

Abbott Laboratories

Eli Lilly and Company

Novartis AG

Johnson & Johnson

Sanofi SA

Teva Pharmaceutical Industries Ltd

Baxter International

Merck & Co. Inc

Boston Scientific Corporation

Report Scope:

In this report, the Global Chronic Pain Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chronic Pain Treatment Market, By Indication:

• Neuropathic Pain
• Analgesic Infusion
• Ablation

Chronic Pain Treatment Market, By Product Type:

• Drugs
• Devices

Chronic Pain Treatment Market, By Distribution Channel:

• Hospital & Clinics
• Ambulatory Centers
• Others

Chronic Pain Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chronic Pain Treatment Market.

Available Customizations:

Global Chronic Pain Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chronic Pain Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Indication (Neuropathic Pain, Analgesic Infusion, Ablation)
  • 5.2.2. By Product Type (Drugs, Devices)
  • 5.2.3. By Distribution Channel (Hospital & Clinics, Ambulatory Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Chronic Pain Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Indication
  • 6.2.2. By Product Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Chronic Pain Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Indication
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Chronic Pain Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Indication
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Chronic Pain Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Indication
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Chronic Pain Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Indication
  • 7.2.2. By Product Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Chronic Pain Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Indication
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Chronic Pain Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Indication
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Italy Chronic Pain Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Indication
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. France Chronic Pain Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Indication
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Chronic Pain Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Indication
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Chronic Pain Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Indication
  • 8.2.2. By Product Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Chronic Pain Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Indication
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Chronic Pain Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Indication
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Chronic Pain Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Indication
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Chronic Pain Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Indication
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Chronic Pain Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Indication
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Distribution Channel

9. South America Chronic Pain Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Indication
  • 9.2.2. By Product Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Chronic Pain Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Indication
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Chronic Pain Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Indication
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Chronic Pain Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Indication
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Chronic Pain Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Indication
  • 10.2.2. By Product Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Chronic Pain Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Indication
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Chronic Pain Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Indication
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Chronic Pain Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Indication
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers & Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Chronic Pain Treatment Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Pfizer Inc
• 14.2. Abbott Laboratories
• 14.3. Eli Lilly and Company
• 14.4. Novartis AG
• 14.5. Johnson & Johnson
• 14.6. Sanofi SA
• 14.7. Teva Pharmaceutical Industries Ltd
• 14.8. Baxter International
• 14.9. Merck & Co. Inc
• 14.10.Boston Scientific Corporation

15. Strategic Recommendations

16. About Us & Disclaimer